Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/260,633external-prioritypatent/US5461031A/en
Application filed by Eli Lilly and CofiledCriticalEli Lilly and Co
Publication of ES2155752A1publicationCriticalpatent/ES2155752A1/es
Application grantedgrantedCritical
Publication of ES2155752B1publicationCriticalpatent/ES2155752B1/es
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Formulaciones de análogos de insulina monoméricos. La presente invención describe diversas formulaciones farmacéuticas parenterales, que comprenden: un análogo de insulina monomérico, cinc, protamina y un derivado fenólico. Las formulaciones de análogos proporcionan una duración prolongada de la actuación. También se describe un procedimiento para la preparación de formulaciones de análogo de insulina-protamina.
ES9802174A1994-06-161995-06-14Formulaciones de analogos de insulina monomericos.
Expired - Fee RelatedES2155752B1
(es)
Nuevos acidos 9-fluor-7-oxo-7h-pirido(1,2,3,-de)(1,4)-benzoxacin-6-carboxilicos y sus esteres, procedimiento para su preparacion y medicamentos que los contienen.